Background-Nonischemic cardiomyopathy is a common cause of left ventricular (LV) dysfunction and myocardial fibrosis. The purpose of this study was to noninvasively evaluate changes in segmental LV extracellular volume (ECV) fraction, LV velocities, myocardial scar, and wall motion in nonischemic cardiomyopathy patients. Methods and Results-Cardiac MRI including pre-and postcontrast myocardial T1 mapping and velocity quantification (tissue phase mapping) of the LV (basal, midventricular, and apical short axis) was applied in 31 patients with nonischemic cardiomyopathy (50±18 years). Analysis based on the 16-segment American Heart Association model was used to evaluate the segmental distribution of ECV, peak systolic and diastolic myocardial velocities, scar determined by late gadolinium enhancement, and wall motion abnormalities. LV segments with scar or impaired wall motion were significantly associated with elevated ECV (r s =0.26; P<0.001) and reduced peak systolic radial velocities (r=−0.43; P<0.001). Regional myocardial velocities and ECV were similar for patients with reduced (n=12; ECV=0.28±0.06) and preserved left ventricular ejection fraction (n=19; ECV=0.30±0.09). Patients with preserved left ventricular ejection fraction showed significant relationships between increasing ECV and reduced systolic (r=−0.19; r=−0.30) and diastolic (r=0.34; r=0.26) radial and long-axis peak velocities (P<0.001). Even after excluding myocardial segments with late gadolinium enhancement, significant relationships between ECV and segmental LV velocities were maintained indicating the potential of elevated ECV to identify regional diffuse fibrosis not visible by late gadolinium enhancement, which was associated with impaired regional LV function.
T he nonischemic cardiomyopathies (NICMs) comprise a diverse group of primary and secondary disorders of the myocardium. 1 Although patient prognosis with an NICM is generally better than with an ischemic cardiomyopathy, treatment and the likelihood of response to therapy is dependent on the specific underlying cardiomyopathy. Current diagnostic tools rely on clinical evaluation combined with assessment of global left ventricular (LV) function by echocardiography. Cardiac MRI has evolved as a valuable tool in the diagnostic work-up of cardiomyopathies, combining quantification of global cardiac function with regional myocardial scar evaluation. [2] [3] [4] [5] Cardiac MRI has proven use in the diagnosis of cardiac amyloidosis, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and noncompaction cardiomyopathy, among others, and is able to differentiate these from ischemic cardiomyopathy through the assessment of regional myocardial scar configuration.
See Clinical Perspective
However, myocardial scar assessment by delayed-enhancement imaging relies on contrast agent uptake in scar tissue relative to normal or remote myocardium. This approach is limited in patients with diffuse myocardial scar without discernable normal myocardium, a situation commonly encountered in myocardial amyloidosis. Moreover, the traditionally used measures of global LV systolic function may underestimate the effect of fibrosis on myocardial function and are insensitive to regional abnormalities in myocardial motion, particularly in patients with preserved left ventricular ejection fraction (LVEF).
Advances in cardiac MRI have enabled quantification of myocardial fibrosis through the calculation of the gadolinium extracellular volume (ECV) fraction using T1-mapping techniques using the modified Look-Locker inversion (MOLLI) recovery method. 6, 7 Calculation of ECV can quantify both regional diffuse and patchy macroscopic myocardial scar and thus potentially improve the assessment of regional myocardial fibrosis. [8] [9] [10] In addition, tissue phase mapping (TPM), a technique using a tridirectional phase contrast sequence mapped to the LV short axes, can be used to quantify regional myocardial velocities during the cardiac cycle along all principal motion directions (radial, long-axis, and circumferential) of the heart. [11] [12] [13] [14] [15] TPM can thus be used to assess regional systolic and diastolic changes in myocardial velocities and may offer an improved sensitivity to detect regional functional abnormalities.
The aim of our study was to analyze in detail segmental ECV and regional myocardial velocities in NICM patients with preserved and with reduced LVEF and to test the hypothesis that NICM results in altered structure (increased ECV) and function (decreased systolic and diastolic myocardial peak velocities). In addition, we hypothesize that changes in regional ECV are more closely associated with impaired regional myocardial motion compared with global indices of LV systolic function, such as the ejection fraction.
Methods

Study Cohort
The study cohort was comprised 31 symptomatic patients (15 men; age=50±18 years) with NICM in normal sinus rhythm. Patients with primary or secondary causes of NICM were included; patients with a history of treated coronary artery disease without residual obstructive lesions in whom LV dysfunction was out of proportion to the extent of treated coronary artery disease were considered to have an NICM and were also included. Patient New York Heart Association (NYHA) stage of heart failure, American Heart Association (AHA) heart failure stage, and current cardiac medications were obtained from the medical record. Where available within 3 months, transthoracic echocardiograms were reviewed to ascertain LV diastolic function. LVEF was defined as preserved at cardiac MRI when >50%. All study subjects were included in accordance with an Institutional Review Board protocol, which permitted retrospective chart review.
MRI
MRI was performed on 1.5T systems (MAGNETOM Avanto, Aera, Siemens, Erlangen, Germany). All patients underwent standard cardiac MRI including late gadolinium enhancement (LGE) for the assessment of myocardial scar and ECG-gated time-resolved (CINE) cardiac MRI for the evaluation of global cardiac function (LVEF, end-diastolic volume, end-systolic volume, and stroke volume) and LV mass. In addition, patients underwent both 2-dimensional TPM and T1 mapping in the short-axis orientation at basal, midventricular, and apical levels.
T1 mapping was performed using a MOLLI recovery technique as described previously by Messroghli et al, 7 using a 17 heart beat acquisition comprising 3 Look-Locker cycles, separated by recovery periods of 3 heart beats. The first and second Look-Locker cycles comprised 3 heartbeats and the third comprised 5 heartbeats. Data for each slice (base, mid, and apex) were acquired during breath holding before and 10 to 25 minutes after the intravenous administration of a contrast agent bolus. Imaging reconstruction included motion correction of the MOLLI images with different inversion times, and the calculation of parametric LV T1 maps as described previously ( Figure 1A ). 16, 17 Imaging parameters were as follows: spatial resolution (pixel size)=2.3×1.8 mm, slice thickness=8 mm, flip angle=35°, acquisition time per short-axis 2-dimensional slice=17 heat beats. Gadopentetate dimeglumine (Magnevist, Bayer Pharmaceuticals, Whippany, NJ) was administered as a bolus infusion at a dose of 0.2 mmol/kg for epidermal growth factor receptor >60 mL/min per 1.73 m 2 or at a dose of 0.1 mmol/kg for epidermal growth factor receptor 31 to 59 mL/min per 1.73 m 2 .
TPM consisted of a black-blood prepared CINE phase-contrast sequence with 3-directional velocity encoding (velocity sensitivity=25 cm/s). 12 Each short-axis slice (basal, mid, and apical location) was acquired during a breath hold ( Figure 1B ). Data were acquired with temporal resolution=24 ms; spatial resolution (pixel size)=2.9×2.4 mm 2 , and slice thickness=8 mm. Spatio-temporal imaging acceleration (k-t parallel imaging PEAK GRAPPA) 18 with a net acceleration factor of R net =3.6 was used, which permitted data acquisition during breath-holding (acquisition time per short-axis 2-dimensional slice=25 heart beats).
Data Analysis-T1 Mapping
The hematocrit was collected within 48 hours of the MRI examination to calculate segmental ECV fraction as described by Kellman et al. 17 By measuring the change in T1 within the blood pool and myocardium before and after contrast agent administration and correcting for the hematocrit the ECV (volume of distribution of gadolinium contrast in the tissue) was calculated as: 
Data Analysis-TPM
The TPM data were analyzed using in-house tools programmed in Matlab (The Mathworks) for correcting background phase offsets, and extracting peak radial and longitudinal velocities at systole and diastole. Analysis included manual segmentation of the LV contours and transformation of the acquired tridirectional velocities into radial velocities representing contraction and expansion in the shortaxis and long-axis velocities as described previously. 19, 20 Long-axis velocities were orthogonal to the short-axis imaging plane. Velocities were defined as positive for systolic contraction/shortening. The resulting velocity components thus describe the myocardial velocities along the axes of the LV, that is, radial contraction and expansion (radial velocities) and long-axis shortening and lengthening (longaxis velocities).
Data Analysis-Regional T1, Myocardial Velocities, and 16-Segment Model
As summarized in Figure 1 , both regional ECV and LV short-and long-axis velocities, were mapped onto the AHA 16-segment model of the left ventricle. 21 The anteroseptal right ventricular and LV insertion point was marked manually and the LV was divided according to the 16-segment model into 6 basal, 6 midventricular, and 4 apical regions of uniform arc lengths.
Mean segmental ECV values were calculated by manually drawing endocardial and epicardial ventricular borders on pre-and postcontrast T1 parametric map acquisitions. In addition, global LV ECV was calculated for each subject as the average ECV over all 16 segments.
In accordance with the work of Kellman 16 evaluating the mean and SD of LV ECV in normal subjects, LV segments with ECV<0.25 were considered normal, segments with ECV between 0.25 and 0.29 (2 SDs above normal) were rated borderline, and segments with ECV≥0.30 were considered elevated.
For TPM, myocardial radial and long-axis velocities were also mapped onto the AHA 16-segment model by averaging velocities for all voxels within each myocardial segment. For all 16 segments, peak systolic and diastolic radial and long-axis velocities were extracted. In addition, global LV systolic and diastolic peak radial and long-axis velocities were calculated for each subject as the average over all 16 segments.
Data Analysis-LGE and Wall Motion Abnormalities
Standard-of-care clinical LGE and cardiac CINE MRI data (basal, midventricular, and apical short-axis orientations in all n=31 patients) were independently qualitatively evaluated by an experienced blinded observer (J.C.) based on the AHA 16-segment model. LGE analysis includes the assessment of presence of delayed enhancement (hyperenhancement compared with remote myocardium) for each segment using a 5-point grading system: 0: no enhancement, 1: enhancement affects <25% (1), 26% to 50% (2), 51% to 75% (3), >75% (4) of the segment volume. Regional wall motion was classified according to the following scheme: normal wall motion (0), mildly hypokinetic (1), moderately hypokinetic (2), severely hypokinetic (3), akinetic (4), or dyskinetic (5).
Statistical Analysis
All MRI data (ECV, myocardial velocities, LGE findings, and wall motion abnormalities) were mapped on the AHA 16-segment model. To compare the regional distribution of myocardial velocities between patient groups (low LVEF, preserved LVEF, normal ECV, borderline ECV, and elevated ECV), a Lilliefors test was used to determine parameter normality followed by 1-way ANOVA (normal distribution) or Kruskal-Wallis test (non-normal distribution). If the overall test was significant (P<0.05), a multiple comparisons procedure was performed. For each segment appropriate post hoc tests (for Gaussian distributions t tests, Mann-Whitney U tests otherwise) were used for paired comparisons of data between patient groups (low versus preserved LVEF, normal versus borderline ECV, borderline versus elevated ECV, and normal versus elevated ECV). The level of significance was adjusted for multiple testing by Bonferroni correction.
To identify relationships between ECV and LV velocities with basic hemodynamic and global cardiac function parameters, and between segmental myocardial peak velocities, ECV, LGE findings, and wall motion abnormalities, Pearson (continuous variables) or Spearman (ordinal data) correlation coefficients r and r S were calculated. For the analysis of associations between region measures of velocities and ECV, data form all segments were included in the analysis.
Results
Patient Cohort
As summarized in Tables 1 and 2 , the patient cohort comprised n=31 subjects with NICM, subdivided clinically and by MRI as n=13 subjects with restrictive cardiomyopathy, n=10 subjects with dilated cardiomyopathy, n=3 subjects with hypertrophic cardiomyopathy, n=3 subjects with inflammatory cardiomyopathy, and n=2 subjects with nonclassified cardiomyopathy. Transthoracic echocardiographically determined LV diastolic function grade, NYHA heart failure stage, AHA heart failure stage, and cardiac medications are listed in Table 2 . Catheter angiography, stress testing, or clinical workup demonstrated no evidence of coronary artery disease in 27 of 31 patients (87%). The remaining 4 patients had a history of remote (>2 years prior) percutaneous coronary intervention without residual significant disease and presented with clinical and imaging findings of a NICM causing their symptoms. . A, T1 mapping is based on diastolic balanced steady state free precession (SSFP) imaging with different inversion recovery (IR) times. B, TPM is based on ECG-gated black-blood prepared phase contrast MRI with 3-directional velocity encoding. Both T1 mapping and TPM were acquired in short-axis orientation (base, mid, apex) during breath-holding. Results from both measurements were mapped on the American Heart Association (AHA) 16-segment model for direct segmental comparison of ECV and LV peak velocities. Regional LV ECV and Velocities in Cardiomyopathy
Relationships With Age, Hemodynamic Parameters, and Global Cardiac Function
Basic hemodynamic parameters, global LV function, myocardial velocities, and ECV are summarized in Table 1 .
Global systolic radial and long-axis velocities were moderately but significantly (P<0.05) associated with LVEF (r=0.51; r=0.36) and inversely correlated to end-systolic volume (r=−0.44; r=−0.39). In addition, there was a significant for the entire study cohort and for subgroups with low and preserved LVEF. Differences between subgroups were evaluated using t tests for Gaussian distributions (*). Otherwise, Mann-Whitney U tests ( †) were used. All data are presented as mean±SD (median, interquartile range). ECV indicates extracellular volume fraction; EDV, end-diastolic volume; ESV, end-systolic volume; LGE, late gadolinium enhancement; LV, left ventricle; LVEF, left ventricular ejection fraction; and SV, stroke volume.
*P values: differences between subgroups with low versus preserved LVEF for Gaussian distributions (t tests). †P values: differences between subgroups with low versus preserved LVEF for non-normal distributions (Mann-Whitney U tests). ‡Significant difference. Regional LV ECV and Velocities in Cardiomyopathy relationship between increased LV mass-to-volume ratio and higher diastolic long-axis velocities (r=0.42). Correlation analysis revealed further associations between systolic radial velocities and stroke volume (r=0.39) and between diastolic long-axis velocities and age (r=0.39). Of note, blood pressure and heart rate did not influence myocardial velocities. For n=30 patients for whom NYHA classification was available ( Table 2) , correlational analysis revealed a significant relationship between increased NYHA grade and reduced peak systolic long-axis velocities (r=−0.54; P=0.002) and elevated ECV (r=0.45; P=0.012).
Myocardial Velocities, Native T1, and ECV-Low Versus Preserved LVEF
Results of a subgroup analysis in patients with low and preserved LVEF ( Table 1) showed that heart rate and blood pressure were similar between groups. Interestingly, levels of global LV precontrast myocardial T1 (native T1) and ECV were similar between patients with reduced and preserved LVEF (native T1=1004±44 versus 1001±57; ECV=0.28±0.06 versus 0.30±0.09, respectively). There were no regional differences in ECV between the reduced and preserved LVEF groups were detected ( Figure 2C ). Global systolic radial velocities were reduced (P=0.02) for low LVEF but all other myocardial velocity components were similar between groups (Table 1). Regional systolic velocities (Figure 2A ) showed significant differences in only 3 of 16 segments for radial and 1 of 16 segments for long-axis velocities between patients with low and preserved LVEF. The distribution of diastolic peak velocities ( Figure 2B ) was similar for patients with low and preserved LVEF except for 1 segment with altered diastolic peak radial velocity. Table 3 summarizes the comparison of regional LV peak velocities in myocardial segments with normal ECV (≤0.25) fraction compared with those with borderline (0.25<ECV<0.3) and elevated (≥0.3) ECV. Segments with elevated ECV demonstrated significantly reduced myocardial velocities compared with regions with normal ECV for systolic radial motion and long-axis velocities. Differences in LV velocities by ECV subgroup were most pronounced for systolic long-axis motion: 6.4±1.1 cm/s for low ECV, 4.2±1.7 cm/s for borderline ECV, and 3.9±1.5 cm/s for elevated ECV (P<0.01). In addition, there was a significant relationship between increased ECV and higher native myocardial T1 (r=0.60; P<0.001).
Myocardial Velocities-Influence of ECV
LGE and Wall Motion Abnormalities
A total number of 72 myocardial segments with scar as demonstrated by LGE were found in 20 of 31 (55%) NICM patients, whereas wall motion abnormalities were present in 17 of 31 (65%) subjects. As expected, LGE was found more frequently in NICM patients with elevated ECV (82%) compared with patients with normal (57%) or borderline ECV (54%). As summarized in Table 4 , there were highly significant relationships between impaired regional wall motion and reduced LV peak velocities, which was most evident for radial systolic velocities (r=−0.43; P<0.001). In addition, the presence and extent of LGE was significantly associated with regionally elevated ECV (r S =0.26; P<0.001).
Correlation of Regional LV Velocities and ECV
For patients with preserved LVEF, correlation analysis (Figure 3) revealed moderate but significant relationships of regional LV systolic and diastolic radial and long-axis peak velocities with regional ECV. Increased ECV was significantly (P<0.001) associated with reduced systolic and diastolic peak velocities in both the short-and long-axes, linking regional myocardial ECV with altered regional myocardial velocities. For NICM patients with reduced LVEF, significant relationships between segments with elevated ECV and regionally altered myocardial velocities were found only for systolic peak velocities (radial: r=−0.3, P<0.001; long axis: r=−0.46, P<0.001).
Noticeably, excluding the 72 segments with visible LGE from the analysis, significant associations between segmental myocardial velocities and ECV were still present for systolic peak velocities (radial: r=−0.15, P=0.001; long axis: r=−0.38, Figure 2 . A, Systolic left ventricular (LV) velocities in patients with nonischemic heart disease with low EF<50% (n=12) compared with a group of n=19 patients with preserved EF (≥50%). The individual plots show the distribution of peak systolic radial and long-axis myocardial velocities in the American Heart Association 16-segment model. B, Diastolic LV velocities. C, LV mapping of extracellular volume (ECV) fraction derived from pre-and postcontrast T1 mapping in the same 2 patient groups. *Significant difference. Regional LV ECV and Velocities in Cardiomyopathy P<0.001) and diastolic long-axis peak velocities (r=0.18; P<0.001).
Discussion
The classical phenotypic description of ventricular function in heart failure has been restricted to LVEF or LV dimension measurements. The arbitrary partitioning of heart failure according to empirically derived measures of LVEF has resulted in overtly heterogeneous patient cohorts, which have in turn complicated clinical trial design and confused clinical trial results. Better phenotypic characterizations are needed, especially for the assessment of those without evidence of ischemic heart disease.
The findings of this study demonstrate the potential of the combined application of advanced cardiac MRI techniques, T1 mapping, and TPM, to detect regional alterations in LV ECV and myocardial velocities. The integration of both methods in 1 MRI examination allowed for the coregistered evaluation of both segmental structural and functional abnormalities. Regional fibrosis burden, as quantified by ECV, was associated with impaired myocardial velocities in patients with NICM. This relationship was maintained even in patients with preserved global LV systolic function.
Our results suggest that elevated regional myocardial ECV adversely affects regional function, reducing peak systolic and diastolic myocardial velocities. Even after excluding myocardial segments with LGE, significant relationships between ECV and segmental LV velocities were maintained. These findings demonstrate the potential of elevated ECV to identify regional diffuse fibrosis not visible by LGE that may be associated with impaired regional LV function. Importantly, LVEF as a global measure of systolic function was less sensitive to changes in myocardial structure, as evaluated with ECV, and was unable to predict altered regional myocardial peak systolic and diastolic velocities. This poor discriminatory function of the LVEF measurement should lead to a re-evaluation of how best to evaluate LV performance in the setting of heart failure and may serve as an explanation for the marked clinical heterogeneity in heart failure cohorts, especially heart failure with preserved ejection fraction.
LGE MRI, part of the standard-of-care cardiac MRI examination, has been extensively used for the phenotypic assessment of ischemic and NICMs and has provided new insights into pathophysiological substrates. 22 A recent meta-analysis demonstrated that LGE has excellent prognostic characteristics to potentially guide risk stratification and management in NICM patients. 4 Other studies, however, have shown that diffuse fibrosis or changes in ECV are difficult to assess with MRI using LGE. 23, 24 As a result, T1 mapping and regional ECV quantification are of high interest as diagnostic tools for NICM. 10 A previous study comparing ECV in patients with hypertrophic cardiomyopathy and NICM compared with controls demonstrated significantly elevated ECV (P<0.01). 25 Similarly, Iles et al 26 showed that T1 mapping could identify changes in myocardial T1 in heart failure, which seemed to reflect the presence of diffuse fibrosis. A recently reported study with 126 patients by Ugander et al 27 showed that ECV could quantitatively characterize myocardial infarction, atypical diffuse fibrosis, and subtle myocardial abnormalities not clinically apparent on LGE images. In agreement with these findings, we found a modest, but significant correlation between qualitatively assessed regional LGE and ECV (r=0.26).
Several previous studies have also investigated the relationship between myocardial ECV and cardiac function. 5 Another recent study investigated diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease demonstrating that ECV correlated with the LV end-diastolic volume index (r=0.60; P<0.001) and negatively with LVEF (r=−0.53; P<0.001). 28 Similar to our findings, both studies indicate that changes in ECV may be a key contributor to contractile dysfunction. However, previous studies relied on measures of global cardiac function, such as LVEF or ventricular dilatation for the assessment of impaired cardiac function, which may limit their potential to detect regional abnormalities in cardiac function. To our knowledge, the direct combination of the assessment of regional ECV with MRI techniques for the quantification of segmental changes in cardiac function as used in our study has not been reported to date. We speculate that because of the patchy distribution of fibrosis in NICM in the myocardium, the combination of structural and functional imaging including all myocardial segments may help to complement the limited information from global LV function parameters and LGE MRI. Assessment of regional myocardial wall motion abnormalities is important and can suggest acute inflammation (inflammatory cardiomyopathy), inflammation or scar (myocardial sarcoidosis) in patients with NICM. In our cohort, quantification of regional myocardial velocities correlated modestly but significantly with qualitative assessment of regional myocardial motion abnormalities (r=−0.43). Similar to our findings with TPM, LVEF alone was an insensitive predictor of regionally altered myocardial motion, as 47% (9 of 19) patients demonstrated regional myocardial motion abnormalities with an LVEF>50%. Assessing regional myocardial velocities is thus of interest as a more sensitive marker for myocardial abnormalities over measures of global systolic and diastolic function alone.
Limitations
Limitations of our study include a small cohort size and the absence of a comparison with an age-matched control cohort without cardiac disease. In addition, the moderate correlation between increased segmental ECV and reduced LV peak velocities limits the significance of our findings and further studies with a larger number of subjects are needed to provide a better understanding of the relationship between ECV and TPM parameters. The heterogeneity of the study population (different types of cardiomyopathies) underscores the feasibility nature of this study and precludes conclusions about the diagnostic effect of this approach characterizing cardiac abnormalities in NICM patients. Moreover, subgroup analysis, such as eccentric versus concentric LV remodeling could not be performed as it would be hampered by the relatively small size of the subgroups. Nevertheless, the observed differences in myocardial velocities between segments with differences in ECV and the significant correlation between ECV and systolic and diastolic myocardial velocities indicate the potential of MRI to better understand the relationship between tissue abnormalities and functional deficits in NICM patients.
A drawback of the MRI protocol used in this study is related to the lengthy breath hold duration for the TPM acquisitions. In our cohort, 11 of 31 patients had signs of dyspnea, which may have led to incomplete breath holding during the TPM acquisition. Nevertheless, all TPM data could successfully be analyzed and data quality was sufficient for epi-and endocardial contour segmentation and calculation of regional peak velocities. It should also be noted that we did not normalize LV velocities for heart rate. However, both heart rate and blood pressure did not influence myocardial velocities (nonsignificant correlation ranging from r=0.07 to r=0.18).
Although assessable by TPM, circumferential velocities and their role in NICM were not investigated in this study. . Correlation analysis between segmental systolic (A) and diastolic (B) left ventricular (LV) peak velocities and regional myocardial extracellular volume (ECV) fraction in patients with nonischemic heart disease and preserved left ventricular ejection fraction (LVEF). The individual graphs show the results of the correlation of regional ECV with myocardial velocities for 19 patients with preserved LVEF on a segment-by-segment basis. For each subject, data form all 16 segments were included, resulting in a total of 19×16=304 data points (ECVmyocardial velocity pairs) for each graph.
Previous studies showed that the circumferential motion of the myocardium is highly complex and can include ≤5 changes in rotational direction during the cardiac cycle in basal segments. 29 It was thus difficult to clearly define systolic and diastolic time points for the segmental evaluation of circumferential velocities. Nevertheless, rotational motion may be valuable for detecting functional deterioration in several forms of NICM and future studies are needed to systematically investigate its diagnostic value.
Investigators have studied multiple T1 MOLLI strategies to shorten the overall acquisition, while maintaining accuracy for T1 estimation across a range of heart rates. We used the original T1 MOLLI approach in our study, acquiring T1 maps over a window of 17 heartbeats. Although the use of shorter breath-held T1 MOLLI techniques, including shortened MOLLI (9 heart beats) 30 and saturation recovery single shot acquisition (10 heart beats) 31 is advantageous in patients with limited breath-holding capabilities, T1 MOLLI images in our cohort were uniformly diagnostic. Recently, optimized shorter pre-and postcontrast MOLLI protocols (11 heartbeats) have been proposed, which can help to reduce breath hold durations in future studies. 32 The selection of the ECV ranges (normal, borderline, and elevated) used in our study was based on previous studies 16 but did not account for possible variability of ECV with age. In our cohort, no correlation of ECV with age was found (P=0.12) but the cutoff at ECV=0.25 between normal and borderline ECV needs to be validated in larger studies with a normal control cohort and different age groups.
ECV values are also dependent on the type of contrast infusion. A bolus approach, such as the one we applied, is easier to use in the clinical setting, but requires that the postcontrast T1 experiment is performed between 10-and 25-minutes after contrast administration. To date, few studies have addressed the unique influence of the chosen contrast agent on ECV values. Our cohort uniformly received gadopentetate dimeglumine at a dose of 0.1 to 0.2 mmol/kg, mitigating these confounding effects.
Conclusions
Our results demonstrate an inverse relationship between regionally elevated ECV and myocardial velocities suggestive of a structure-function relationship at the segmental level where increasing degrees of myocardial scar burden adversely affect regional systolic and diastolic functions. Global assessment of LV systolic function using the LVEF was less sensitive to regional myocardial changes in NICM. Segmental ECV and TPM analysis may be useful to detect early changes in patients with cardiomyopathies with focal regional involvement, such as hypertrophic cardiomyopathy, myocardial sarcoidosis, and inflammatory cardiomyopathies among others.
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